Financhill
Sell
15

THRY Quote, Financials, Valuation and Earnings

Last price:
$15.14
Seasonality move :
9.07%
Day range:
$14.95 - $15.74
52-week range:
$13.06 - $26.42
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.70x
P/B ratio:
3.33x
Volume:
749.2K
Avg. volume:
481.2K
1-year change:
-31.15%
Market cap:
$655.8M
Revenue:
$824.2M
EPS (TTM):
-$2.09

Analysts' Opinion

  • Consensus Rating
    Thryv Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $26.75, Thryv Holdings has an estimated upside of 76.92% from its current price of $15.12.
  • Price Target Downside
    According to analysts, the lowest downside price target is $24.00 representing 100% downside risk from its current price of $15.12.

Fair Value

  • According to the consensus of 3 analysts, Thryv Holdings has 76.92% upside to fair value with a price target of $26.75 per share.

THRY vs. S&P 500

  • Over the past 5 trading days, Thryv Holdings has underperformed the S&P 500 by -1.8% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Thryv Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Thryv Holdings revenues have been falling on a year-over-year basis for 8 quarters in a row. In the most recent quarter Thryv Holdings reported revenues of $186.6M.

Earnings Growth

  • Thryv Holdings earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Thryv Holdings reported earnings per share of $0.19.
Enterprise value:
923.8M
EV / Invested capital:
1.92x
Price / LTM sales:
0.70x
EV / EBIT:
--
EV / Revenue:
1.12x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
16.42x
Price / Operating cash flow:
10.25x
Enterprise value / EBITDA:
27.53x
Gross Profit (TTM):
$537.2M
Return On Assets:
-9.97%
Net Income Margin (TTM):
-9.01%
Return On Equity:
-46.72%
Return On Invested Capital:
-15.3%
Operating Margin:
-3.86%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $1.2B $917M $824.2M $236.2M $186.6M
Gross Profit $780.4M $578.2M $537.2M $159.7M $123M
Operating Income $201.5M $68.8M $49.8M $26.7M -$7.2M
EBITDA $247.8M -$135.6M $33.6M -$219.5M $30.8M
Diluted EPS $1.39 -$7.49 -$2.09 -$7.39 $0.19
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $369.7M $370.6M $378.3M $266.9M $210.7M
Total Assets $1.2B $1.3B $1.2B $783.2M $712.2M
Current Liabilities $207.4M $307.1M $300.5M $263.2M $196.3M
Total Liabilities $1B $985.8M $795.6M $630.5M $515.2M
Total Equity $196.8M $314.7M $382.3M $152.7M $196.9M
Total Debt $528.4M $562.5M $469.8M $348.9M $284.3M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $148.6M $148.2M $89.8M $44.6M $26.1M
Cash From Investing -$52M -$42.5M -$110.4M -$10.5M -$85.7M
Cash From Financing -$91.1M -$103.5M $19.2M -$31.4M $64.7M
Free Cash Flow $119.3M $114.8M $56.2M $34.1M $17.3M
THRY
Sector
Market Cap
$655.8M
$88.3M
Price % of 52-Week High
57.23%
65.54%
Dividend Yield
0%
0%
Shareholder Yield
--
3.14%
1-Year Price Total Return
-31.15%
-12.74%
Beta (5-Year)
1.081
0.690
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $15.30
200-day SMA
Sell
Level $17.07
Bollinger Bands (100)
Sell
Level 14.45 - 17.73
Chaikin Money Flow
Sell
Level -11.6M
20-day SMA
Sell
Level $16.52
Relative Strength Index (RSI14)
Sell
Level 35.56
ADX Line
Sell
Level 19.89
Williams %R
Buy
Level -88.7029
50-day SMA
Sell
Level $16.90
MACD (12, 26)
Sell
Level -0.69
25-day Aroon Oscillator
Sell
Level -40
On Balance Volume
Neutral
Level 11.2M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.7089)
Sell
CA Score (Annual)
Level (-1.3702)
Buy
Beneish M-Score (Annual)
Level (-3.7366)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (3.7743)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. Its company is built upon a rich legacy in the marketing and advertising industry. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable SMB clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation, and run their day-to-day operations to save time, compete and win in today's SMB environment. The group has two business segments; Thryv SaaS and Thryv Marketing Services.

Stock Forecast FAQ

In the current month, THRY has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The THRY average analyst price target in the past 3 months is $26.75.

  • Where Will Thryv Holdings Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Thryv Holdings share price will rise to $26.75 per share over the next 12 months.

  • What Do Analysts Say About Thryv Holdings?

    Analysts are divided on their view about Thryv Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Thryv Holdings is a Sell and believe this share price will drop from its current level to $24.00.

  • What Is Thryv Holdings's Price Target?

    The price target for Thryv Holdings over the next 1-year time period is forecast to be $26.75 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is THRY A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Thryv Holdings is a Buy. 3 of 3 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of THRY?

    You can purchase shares of Thryv Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Thryv Holdings shares.

  • What Is The Thryv Holdings Share Price Today?

    Thryv Holdings was last trading at $15.14 per share. This represents the most recent stock quote for Thryv Holdings. Yesterday, Thryv Holdings closed at $15.12 per share.

  • How To Buy Thryv Holdings Stock Online?

    In order to purchase Thryv Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Sportradar Stock Going Up?
Why Is Sportradar Stock Going Up?

Sportradar (NASDAQ:SRAD) should be on your radar for a stock…

Is Roblox Stock a Buy, Sell or Hold?
Is Roblox Stock a Buy, Sell or Hold?

Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock